CLOSE

Benchmark Investments

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
33.68 -0.06(-0.17%) NAV as on 20 Aug 2026
1.13 % 1 M
8.12 % 1 Y
18.67 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.28

As on 31 Jul, 2026
Age :

10 yrs 7 m

Since 28 12 ,2015
Exit Load :

0.25%

AUM :

1,541.42 Crs

Portfolio Price To Book Value :

8.4

Investing Style :

Mid Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Rajat Srivastava

Launch Date :

28-Dec-15

Scheme Benchmark :

NA

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jul 31 ,2026
Others 0.86 %
Equity 99.14 %

TOP HOLDINGS

Sun Pharmaceutical Industries...8.59 %
Divi's Laboratories Ltd.6.36 %
Healthcare Global Enterprises...5.85 %
Abbott India Ltd.5.63 %
Rainbow Children's Medicare Ltd.4.90 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.30
Hospital & Healthcare Services28.92
Pesticides & Agrochemicals4.85
Business Support2.95
Household & Personal Products1.15
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)17.1815.8825.0628.6428.10
Net Assets(Rs Crores) (as on 31-Mar-2026) 553.33 493.44 878.70 1183.65 1229.42
Scheme Returns(%)(Absolute)16.04-7.3157.4613.01-0.81
B'mark Returns(%)(Absolute)NANANANANA
Category Rank41/7567/7619/9020/10251/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2026-202715.06NANANA
2025-20265.44-0.660.70-6.98
2024-20254.6218.851.96-9.86
2023-202415.1911.1111.3810.75
2022-2023-10.368.14-0.52-4.19

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity33.68-0.06(-0.17%)NAV As on 20 Aug, 202628-Dec-2015Inception Date1,541.42AUM In Cr.8.12%1Y18.67%3Y13.80%5Y12.07%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity340.43-0.50(-0.15%)NAV As on 20 Aug, 202601-Aug-2005Inception Date1,370.92AUM In Cr.15.03%1Y23.11%3Y15.27%5Y18.23%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd